A popular obesity drug may help treat a dangerous disorder in which people struggle to breathe while they sleep, a new study finds. Tirzepatide, the medication in the weight-loss drug Zepbound and also the diabetes treatment Mounjaro, appeared to reduce the severity of sleep apnea along with reducing weight and improving blood pressure and other […]
Obesity isn’t just a matter of food and exercise — it may be in your genetic code, according to new research. “Obesity’s causes are very complex and in the majority of cases, the combination of many factors. In this study, however, we found a clear genetic trigger for obesity,” said lead study author Dr. Mattia […]
Overweight and obesity in children and adolescents continues to be highlighted as a global health issue, as new research published by JAMA Pediatrics finds that, worldwide, 1 in 5 people under the age of 18 have experienced excess weight. The review of global studies revealed that the prevalence of obesity saw a 150% increase from […]
Grammy Award-winning singer and American Idol alum Mandisa died of complications from class III obesity, according to an autopsy report obtained by People. The 47-year-old was found dead by friends in her Franklin, Tenn., home on April 18 and her manner of death was listed as natural. What does it mean to die from obesity? […]
Grammy Award-winning singer and American Idol alum Mandisa died of complications from class III obesity, according to an autopsy report obtained by People. The 47-year-old was found dead by friends in her Franklin, Tenn., home on April 18 and her manner of death was listed as natural. What does it mean to die from obesity? […]
Weight loss translates to investor profits. Just look at Eli Lilly and Novo Nordisk. Both stocks have skyrocketed thanks largely to their obesity drugs, with Lilly’s share price more than quadrupling and Novo’s shares more than tripling over the last three years. Meanwhile, Pfizer‘s (NYSE: PFE) fortunes have taken a different path. The big pharma […]
(Bloomberg) — Amgen Inc.’s shares soared in late trading after its chief executive officer said he was “very encouraged” by early results from a study of the company’s experimental obesity drug, MariTide. Most Read from Bloomberg “We recognize the significant interest in obesity,” Amgen CEO Robert Bradway said Thursday on a call with investors. “We […]
Amgen (AMGN) stock surged late Thursday on its first-quarter profit beat as investors zero in on its potential rivals to Eli Lilly‘s (LLY) and Novo Nordisk‘s (NVO) obesity treatments.
(Updates shares in paragraph 3, explanation of share drop in paragraph 4) By Maggie Fick LONDON, May 2 (Reuters) – Novo Nordisk raised its 2024 outlook on Thursday and delivered better-than-expected first-quarter profits as the Danish drugmaker races to boost output of its Wegovy weight-loss drug and fend off competition from rival Eli Lilly. Novo […]
By Maggie Fick LONDON (Reuters) – Novo Nordisk raised its 2024 outlook on Thursday and delivered better-than-expected quarterly profits as the Danish drugmaker races to boost output of its hugely popular weight-loss drug Wegovy and fend off competition from rival Eli Lilly. The small raise to the outlook and forecast-beating results underscore Wegovy’s success and […]
More than 2 in 5 adults in the U.S. have obesity, and rates of the condition have increased over time. But research has repeatedly found that obesity is a complicated disease, and for some, the condition has a genetic component. Now, a new study finds that people at a higher genetic risk of obesity may […]
More than 2 in 5 adults in the U.S. have obesity, and rates of the condition have increased over time. But research has repeatedly found that obesity is a complicated disease, and for some, the condition has a genetic component. Now, a new study finds that people at a higher genetic risk of obesity may […]